Table of Contents
What does BLA filing mean?
Biologics License Application
The Biologics License Application (BLA) is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680.
What is difference between NDA and BLA?
An NDA is an application to permit the sale and marketing of a new drug in the United States. Drugs that are approved via an NDA pathway are regulated under Section 505 of the Food, Drug, & Cosmetics (FD&C) Act. A BLA is a request to introduce, or deliver for introduction, a biological product into interstate commerce.
How long does a BLA approval take?
Review Timeline As per the Prescription Drug User Fee Act (PDUFA), the FDA agreed to review the majority of BLAs within 10 months of 60 day filing and for the priority submissions it has been cut down to 6 months of 60 day filing date.
What are the requirements for submitting a BLA?
A BLA is submitted by an applicant (manufacturer) and must contain data derived from non-clinical laboratory and clinical studies which, demonstrate that the manufactured product meets prescribed requirements of safety, purity, and potency (21 CFR Part 601.2).
What is BLA in FDA approval?
A Biologics License Application, or BLA, is FDA’s standard “full approval” mechanism for biological products, including therapeutics and vaccines. A company receiving a BLA for their product can introduce the product into interstate commerce and market it for its approved uses.
How long does it take the FDA to review a BLA?
Current FDA performance goals under the Prescription Drug User Fee Act (PDUFA) stipulate that FDA intends to review and act on 90\% of standard NDA and BLA submissions within 10 months of the filing date. The goal for priority review applications is 6 months.
What is IND and BLA?
Investigational New Drug (IND) Application. New Drug Application (NDA) Therapeutic Biologics Applications (BLA)
What is a BLA vs IND?
The application tells the products full story of development and supports its use for a specific disease condition. The IND application precedes the BLA / NDA application, and the IND is actually part of the BLA / NDA as it is the living document that is kept up to date throughout the clinical evaluation process.
How long does the FDA take to approve a BLA?
At the end of your Phase III trial, you can submit your BLA to the FDA, but it can still take up to two years to gain approval.
How do I submit a BLA to the FDA?
We’ve helped many companies—big and small—plan and navigate the BLA process successfully, on time and on budget.
- Apply for a Biologics License Application.
- Submit a Form FDA 356h.
- Await FDA Review.
What is a BLA supplement?
BLA Supplement means a supplement to a BLA Application filed with the FDA pursuant to 21 C.F.R. § 601.2 et seq., (or any foreign equivalent) filed with the Regulatory Authorities in a country or territory to modify or amend the referenced BLA including, inter alia, to add a Baxter Facility to the BLA.
What is BLA in pharmaceuticals?
A Biologics License Application, or BLA, is FDA’s standard “full approval” mechanism for biological products, including therapeutics and vaccines.
What is a BLA for Biologics?
A Biologics License Application (BLA) is submitted to the Food and Drug Administration (FDA) to obtain permission for distribution of a biologic product across the states. It is regulated under 21 CFR 600-680. A BLA can be submitted by an applicant who is responsible for the safety and efficacy of the product.
What is a BLA and who needs one?
The BLA is regulated under 21 CFR 600 – 680. A BLA is submitted by any legal person or entity who is engaged in manufacture or an applicant for a license who takes responsibility for compliance with product and establishment standards. Form 356h specifies the requirements for a BLA. This includes:
What does BLA stand for?
The Biologics License Application (BLA) is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under…
What is the difference between an NDA and a BLA?
Whereas a new drug application (NDA) is used for drugs subject to the drug approval provisions of the FDC Act, a biologics license application (BLA) is required for biological products subject to licensure under the PHS Act. FDA form 356h is used for both NDA and BLA submissions.